Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
98 EUR | -1.01% | -.--% | +2.08% |
06:22am | Eli Lilly Sues More Wellness Centers, Medical Spas Over Unauthorized Tirzepatide Sales | MT |
06-20 | Health Care Stocks Rise Behind Gilead -- Health Care Roundup | DJ |
Sales 2024 * | 42.98B 40.1B 3,394B | Sales 2025 * | 52.62B 49.09B 4,155B | Capitalization | 798B 744B 62,995B |
---|---|---|---|---|---|
Net income 2024 * | 11.93B 11.13B 942B | Net income 2025 * | 16.55B 15.44B 1,307B | EV / Sales 2024 * | 19 x |
Net Debt 2024 * | 18.06B 16.85B 1,426B | Net Debt 2025 * | 15B 13.99B 1,184B | EV / Sales 2025 * | 15.4 x |
P/E ratio 2024 * |
66.3
x | P/E ratio 2025 * |
47.7
x | Employees | - |
Yield 2024 * |
0.59% | Yield 2025 * |
0.68% | Free-Float | 99.8% |
Latest transcript on Eli Lilly and Company
1 day | -1.01% |
Managers | Title | Age | Since |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 31/12/95 |
Ruth Gimeno
PSD | President | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 15/10/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 24/01/21 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 31/03/09 |
Jon Fyrwald
BRD | Director/Board Member | 63 | 31/12/04 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.72% | 356B | |
+18.94% | 328B | |
+11.07% | 304B | |
+16.96% | 244B | |
+2.25% | 227B | |
+11.15% | 216B | |
+7.59% | 166B | |
-3.65% | 157B | |
-1.84% | 118B |
- Stock Market
- Equities
- LLY Stock
- LLY Stock